Abstract

An anonymous $275 million gift propels the Sanford-Burnham Medical Research Institute more than halfway to its funding goal for a newly announced 10-year drug development plan that involves speeding the development of preclinical therapies that it hopes to out-license.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call